Show Notes
For this week’s episode, we’re putting the spotlight on another business that has been making headlines recently.
The supply chain issue has been one we’ve heard a lot about since Covid hit, and globally we are still seeing issues in some countries struggling to clear the backlog. But now that things are open again, what’s the story?
Madison is joined by Mark Troughear from Freightways to discuss the situation in New Zealand - and learn why our postage should cost twice what it does. See omnystudio.com/listener for privacy information.
More from Continuous Disclosure
It's time for another wrap of the markets - August saw many New Zealand companies report their earnings, with interesting insights into the state of the economy, while overseas, there is one thing that has investors and analysts interested and that is Ozempic! For this last episode of the season, Madison is joined by Fisher Funds Senior Portfolio Manager Sam Dickie to analyse the global markets.
It’s official - New Zealand was in a period of technical recession at the beginning of this year, according to GDP figures out this month.
There have not been any new companies listed on the NZX since December last year - so why is there such a dearth of companies publicly listing, and is there anything we can do to change that case?
The cost of medicine is always controversial, particularly in an election year. We’ve already seen the Government scrap prescription fees to make them more accessible – but what sort of costs really go in to making and licensing medicine, and how does being publicly listed impact a drugs company?
Over the last few weeks, Auckland Mayor Wayne Brown has attempted to get councillors on side with his desire to sell the council’s shares in Auckland Airport.